Stabilization period [Design Issues]

posted by dshah  – India/United Kingdom, 2023-06-27 10:46 (96 d 20:56 ago) – Posting: # 23618
Views: 451

Dear Vismayi!

❝ In this study,we need to stabilize patients but for how many days neither it is mentioned in specific guidance nor product leaflet. So, what duration we should we consider for stabilization.

Generally patient are already on this medication. Stabilization periods means you have reached steady state with that formulation which generally takes about 3-5 half life of drug. Confirm after dosing for 3-5 halflife that C0 are constant. When changing the treatment, the same stabilization with new formulation needs to be applied.

❝ Beside,study product can be taken until patient tolerate as per leaflet.

❝ If the disease pre-valence is less and this may lead to challenge in recruitment. So can we consider replicate design over conventional two-way.

If you are deviating from PSG- either design or healthy subject- kindly do CC with authority. Many a times, not even a single dose is re­comm­ended to HV.


Complete thread:

UA Flag
 Admin contact
22,763 posts in 4,775 threads, 1,628 registered users;
10 visitors (0 registered, 10 guests [including 2 identified bots]).
Forum time: 07:42 CEST (Europe/Vienna)

The object of statistics is information.
The objective of statistics is the understanding of information
contained in data.    Irwin and Marylees Miller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz